119 related articles for article (PubMed ID: 28512027)
1. Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs.
Verhasselt S; Stevens CV; Van den Broecke T; Bracke ME; Roman BI
Bioorg Med Chem Lett; 2017 Jul; 27(13):2986-2989. PubMed ID: 28512027
[TBL] [Abstract][Full Text] [Related]
2. Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs.
Verhasselt S; Roman BI; Bracke ME; Stevens CV
Eur J Med Chem; 2017 Aug; 136():85-103. PubMed ID: 28486210
[TBL] [Abstract][Full Text] [Related]
3. Discovery of (S)-3'-hydroxyblebbistatin and (S)-3'-aminoblebbistatin: polar myosin II inhibitors with superior research tool properties.
Verhasselt S; Roman BI; De Wever O; Van Hecke K; Van Deun R; Bracke ME; Stevens CV
Org Biomol Chem; 2017 Mar; 15(9):2104-2118. PubMed ID: 28220174
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of C-ring-modified blebbistatin derivatives and evaluation of their myosin II ATPase inhibitory potency.
Roman BI; Verhasselt S; Mangodt CW; De Wever O; Stevens CV
Bioorg Med Chem Lett; 2018 Jul; 28(13):2261-2264. PubMed ID: 29807794
[TBL] [Abstract][Full Text] [Related]
5. The structural basis of blebbistatin inhibition and specificity for myosin II.
Allingham JS; Smith R; Rayment I
Nat Struct Mol Biol; 2005 Apr; 12(4):378-9. PubMed ID: 15750603
[TBL] [Abstract][Full Text] [Related]
6. Specificity of blebbistatin, an inhibitor of myosin II.
Limouze J; Straight AF; Mitchison T; Sellers JR
J Muscle Res Cell Motil; 2004; 25(4-5):337-41. PubMed ID: 15548862
[TBL] [Abstract][Full Text] [Related]
7. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction.
Wang HH; Tanaka H; Qin X; Zhao T; Ye LH; Okagaki T; Katayama T; Nakamura A; Ishikawa R; Thatcher SE; Wright GL; Kohama K
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2060-8. PubMed ID: 18296570
[TBL] [Abstract][Full Text] [Related]
8. Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
Roman BI; Verhasselt S; Stevens CV
J Med Chem; 2018 Nov; 61(21):9410-9428. PubMed ID: 29878759
[TBL] [Abstract][Full Text] [Related]
9. para-Nitroblebbistatin, the non-cytotoxic and photostable myosin II inhibitor.
Képiró M; Várkuti BH; Végner L; Vörös G; Hegyi G; Varga M; Málnási-Csizmadia A
Angew Chem Int Ed Engl; 2014 Jul; 53(31):8211-5. PubMed ID: 24954740
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of blebbistatin inhibition of myosin II.
Kovács M; Tóth J; Hetényi C; Málnási-Csizmadia A; Sellers JR
J Biol Chem; 2004 Aug; 279(34):35557-63. PubMed ID: 15205456
[TBL] [Abstract][Full Text] [Related]
11. Block the function of nonmuscle myosin II by blebbistatin induces zebrafish embryo cardia bifida.
Wang X; Chong M; Wang X; Wang H; Zhang J; Xu H; Zhang J; Liu D
In Vitro Cell Dev Biol Anim; 2015 Mar; 51(3):211-7. PubMed ID: 25403653
[TBL] [Abstract][Full Text] [Related]
12. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor.
Straight AF; Cheung A; Limouze J; Chen I; Westwood NJ; Sellers JR; Mitchison TJ
Science; 2003 Mar; 299(5613):1743-7. PubMed ID: 12637748
[TBL] [Abstract][Full Text] [Related]
13. Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression.
Kabaeva Z; Zhao M; Michele DE
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1667-74. PubMed ID: 18296569
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin.
Eddinger TJ; Meer DP; Miner AS; Meehl J; Rovner AS; Ratz PH
J Pharmacol Exp Ther; 2007 Feb; 320(2):865-70. PubMed ID: 17132816
[TBL] [Abstract][Full Text] [Related]
15. A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative.
Várkuti BH; Képiró M; Horváth IÁ; Végner L; Ráti S; Zsigmond Á; Hegyi G; Lenkei Z; Varga M; Málnási-Csizmadia A
Sci Rep; 2016 May; 6():26141. PubMed ID: 27241904
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor.
Duxbury MS; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Jan; 313(4):992-7. PubMed ID: 14706640
[TBL] [Abstract][Full Text] [Related]
17. Blebbistatin and blebbistatin-inactivated myosin II inhibit myosin II-independent processes in Dictyostelium.
Shu S; Liu X; Korn ED
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1472-7. PubMed ID: 15671182
[TBL] [Abstract][Full Text] [Related]
18. Improved Inhibitory and Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) Properties of Blebbistatin Derivatives Indicate That Blebbistatin Scaffold Is Ideal for drug Development Targeting Myosin-2.
Gyimesi M; Rauscher AÁ; Suthar SK; Hamow KÁ; Oravecz K; Lőrincz I; Borhegyi Z; Déri MT; Kiss ÁF; Monostory K; Szabó PT; Nag S; Tomasic I; Krans J; Tierney PJ; Kovács M; Kornya L; Málnási-Csizmadia A
J Pharmacol Exp Ther; 2021 Mar; 376(3):358-373. PubMed ID: 33468641
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Selective Inhibitors for
Radnai L; Surman M; Hafenbreidel M; Young EJ; Stremel RF; Lin L; Bdiri B; Pasetto P; Jin X; Geedy M; Partridge JR; Patel A; Conlon M; Sellers JR; Cameron MD; Rumbaugh G; Griffin PR; Kamenecka TM; Miller CA
ACS Chem Biol; 2021 Nov; 16(11):2164-2173. PubMed ID: 34558887
[TBL] [Abstract][Full Text] [Related]
20. The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.
Lucas-Lopez C; Allingham JS; Lebl T; Lawson CP; Brenk R; Sellers JR; Rayment I; Westwood NJ
Org Biomol Chem; 2008 Jun; 6(12):2076-84. PubMed ID: 18528569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
